{
  "retracted": false,
  "timestamp": 1537315200000,
  "updates": [
    {
      "timestamp": 1568850031256,
      "identifier": {
        "doi": "10.1038/s41375-018-0241-7"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/leu.2017.276"
  },
  "journal": "Leukemia",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction: Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia"
}
